ANASTROZOLE TEVA

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

ANASTROZOLE

Available from:

TEVA ISRAEL LTD

ATC code:

L02BG03

Pharmaceutical form:

TABLETS

Composition:

ANASTROZOLE 1 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutic group:

ANASTROZOLE

Therapeutic area:

ANASTROZOLE

Therapeutic indications:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Authorization date:

2014-07-31

Patient Information leaflet

PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor's prescription only
ANASTROZOLE TEVA
®
TABLETS
COMPOSITION
Each tablet contains:
Anastrozole 1 mg
For information regarding inactive ingredients and allergens,
see the subsection “Important information about some of
the ingredients of the medicine” and section 6 – “Additional
information”.
READ
THE
ENTIRE
LEAFLET
CAREFULLY
BEFORE
USING
THE
MEDICINE. This leaflet contains concise information about
the medicine. If you have additional questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for treatment of your
illness. Do not pass it on to others. It may harm them even if
it seems to you that their illness is similar.
This medicine is not intended for children and adolescents.
1. WHAT IS THE MEDICINE INTENDED FOR?
Treatment of advanced breast cancer in post-menopausal
women.
THERAPEUTIC GROUP
Aromatase enzyme inhibitors.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient
anastrozole or to any of the other ingredients this
medicine contains (please see section 6 – “Additional
information”)
•
You are pregnant or breastfeeding (see the subsection
“Pregnancy and breastfeeding”)
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
BEFORE THE TREATMENT WITH ANASTROZOLE TEVA, TELL THE
DOCTOR IF:
•
You still have menstrual periods and have not yet gone
through the menopause
•
You are taking a medicine that contains tamoxifen or
medicines
that
contain
estrogen
(see
the
subsection
“Drug interactions”)
•
You are suffering or have suffered in the past from any
condition that affects bone strength (osteoporosis)
•
You have liver or kidney problems
ADDITIONAL WARNINGS
•
In the event that you go to a hospital you must inform the
medical staff that you are taking Anastrozole Teva
DRUG INTERACTIONS
IF YOU ARE TAKING OR HAVE RECENTLY TAKEN OTHER MEDICINES,
INCLUDING NON-PRESCRIP